<?xml version='1.0' encoding='us-ascii'?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">
<DOCID>59</DOCID>
<TEXT>
Exhibit . [***] Certain information in this document has been <EVENT class="COREFERENCE" eid="e0">excluded</EVENT> pursuant to Regulation S-K, Item (b)( ). Such excluded information is not material and would likely <EVENT class="COREFERENCE" eid="e1">cause</EVENT> competitive <EVENT class="COREFERENCE" eid="e2">harm</EVENT> to the registrant if publicly <EVENT class="COREFERENCE" eid="e3">disclosed</EVENT> . Execution Copy LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT <EVENT class="COREFERENCE" eid="e4">DATED</EVENT> AS OF FEBRUARY , BY AND BETWEEN XENCOR, INC. AND AIMMUNE THERAPEUTICS, INC. Source: AIMMUNE THERAPEUTICS, INC., -K, / / TABLE OF CONTENTS Page ARTICLE Definitions ARTICLE Licenses ARTICLE Development ARTICLE Regulatory ARTICLE Commercialization ARTICLE Supply ARTICLE Payments ARTICLE Payment; Records; Audits ARTICLE Intellectual Property Matters ARTICLE Representations, Warranties and Covenants; Compliance ARTICLE Indemnification ARTICLE Confidentiality ARTICLE Term and Termination ARTICLE Effects of Expiration Or Termination ARTICLE Miscellaneous Schedule . Antibody Schedule . Xencor General Patents Schedule . Xencor Product Specific Patents Schedule . Xencor Know-How, Regulatory Materials, and Regulatory Data Schedule . Initial Product Supply Schedule . . Exceptions Schedule . Initial Press Release Source: AIMMUNE THERAPEUTICS, INC., -K, / / LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT This License, Development and Commercialization Agreement (this "Agreement"), <EVENT class="COREFERENCE" eid="e5">dated</EVENT> as of February , (the "Effective Date "), is <EVENT class="COREFERENCE" eid="e6">made</EVENT> by and between Xencor, Inc. ("Xencor"), and Aimmune Therapeutics, Inc. ("Aimmune"). Xencor and Aimmune are sometimes <EVENT class="COREFERENCE" eid="e7">referred</EVENT> to herein individually as a "Party" and collectively as the "Parties". RECITALS WHEREAS, Xencor has <EVENT class="COREFERENCE" eid="e8">developed</EVENT> the Antibody (as <EVENT class="COREFERENCE" eid="e9">defined</EVENT> below); WHEREAS, Aimmune is interested in further <EVENT class="COREFERENCE" eid="e10">developing</EVENT> and <EVENT class="COREFERENCE" eid="e11">commercializing</EVENT> the Antibody; and WHEREAS, Xencor <EVENT class="COREFERENCE" eid="e12">wishes</EVENT> to <EVENT class="COREFERENCE" eid="e13">grant</EVENT> a license to Aimmune under certain intellectual property rights <EVENT class="COREFERENCE" eid="e14">related</EVENT> to the Antibody to <EVENT class="COREFERENCE" eid="e15">develop</EVENT> , <EVENT class="COREFERENCE" eid="e16">manufacture</EVENT> and <EVENT class="COREFERENCE" eid="e17">commercialize</EVENT> the Product (as <EVENT class="COREFERENCE" eid="e18">defined</EVENT> below), and Aimmune <EVENT class="COREFERENCE" eid="e19">wishes</EVENT> to <EVENT class="COREFERENCE" eid="e20">take</EVENT> such license, in each case in accordance with the terms and conditions set forth below. NO W THEREFORE, in consideration of the foregoing premises and the mutual promises, covenants and conditions <EVENT class="COREFERENCE" eid="e21">contained</EVENT> in this Agreement, and for other good and valuable consideration, <EVENT class="COREFERENCE" eid="e22">receipt</EVENT> of which is hereby <EVENT class="COREFERENCE" eid="e23">acknowledged</EVENT> , the Parties <EVENT class="COREFERENCE" eid="e24">agree</EVENT> as follows : ARTICLE DEFINITIONS As <EVENT class="COREFERENCE" eid="e25">used</EVENT> in this Agreement, the following initially <EVENT class="COREFERENCE" eid="e26">capitalized</EVENT> terms shall have the meanings set forth in this ARTICLE or as otherwise <EVENT class="COREFERENCE" eid="e27">defined</EVENT> elsewhere in this Agreement: . "Active Ingredient" means any substance (whether chemical or biologic) or mixture of substances intended to be used in the <EVENT class="COREFERENCE" eid="e28">manufacture</EVENT> of a drug (medicinal) product that, when used in the <EVENT class="COREFERENCE" eid="e29">production</EVENT> of such drug, becomes a therapeutically active ingredient of the drug product, and which such substance or mixture of substances is intended to furnish pharmacological <EVENT class="COREFERENCE" eid="e30">activity</EVENT> or other direct <EVENT class="COREFERENCE" eid="e31">effect</EVENT> in the <EVENT class="COREFERENCE" eid="e32">diagnosis</EVENT> <EVENT class="COREFERENCE" eid="e33">cure</EVENT> <EVENT class="COREFERENCE" eid="e34">mitigation</EVENT> <EVENT class="COREFERENCE" eid="e35">treatment</EVENT> or <EVENT class="COREFERENCE" eid="e36">prevention</EVENT> of disease or to affect the structure or function of the body. . "Affiliate" means with respect to any person, any other person directly or indirectly controlling, controlled by, or under common control with such person; provided, that, for purposes of this definition, "control" (including, with correlative meanings, the terms "controlled by" and "under common control with"), as used with respect to any person, shall mean (i) the possession, directly or indirectly, of the power to direct or cause the direction of the <EVENT class="COREFERENCE" eid="e37">management</EVENT> and policies of such person, whether through the ownership of voting securities or by contract or otherwise, or (ii) the ownership, directly or indirectly, of fifty percent ( %) or more of the voting securities of such person. For purposes of this Section . , "person" means mean an individual, corporation, partnership, limited partnership, limited liability company, limited liability partnership, syndicate, person (including a "person" as defined in Section (d)( ) of the Securities Exchange Act of , as amended, together with the rules and regulations promulgated thereunder), trust, association, entity or government or political subdivision, agency or instrumentality of a government. Source: AIMMUNE THERAPEUTICS, INC., -K, / / . "Aimmune Agreement Entities" means Aimmune's Affiliates and Sublicensees (excluding distributors). . "Aimmune Common Stock" means Aimmune's common stock, par value $ . per share. . "Aimmune Field" means the field of [***]. . "Aimmune Invention" means an Invention that is Invented, solely or jointly with a Third Party, by or on behalf of Aimmune or its Affiliates. . "Aimmune Know-How" means any and all Know-How, whether or not patented or patentable, that is Controlled by Aimmune or its Affiliates as of the Effective Date or at any time during the Term that is necessary or reasonably useful in connection with the <EVENT class="COREFERENCE" eid="e38">Development</EVENT> <EVENT class="COREFERENCE" eid="e39">Manufacture</EVENT> <EVENT class="COREFERENCE" eid="e40">Commercialization</EVENT> or other <EVENT class="COREFERENCE" eid="e41">use</EVENT> of the Antibody or Product. . "Aimmune Patent" means any Patent that (i) (a) is Controlled by Aimmune (or its Affiliates) as of the Effective Date or comes under the Control of Aimmune (or its Affiliates) during the Term (other than as a result of the licenses granted by Xencor to Aimmune under this Agreement) and (b) that would be infringed by the <EVENT class="COREFERENCE" eid="e42">Development</EVENT> <EVENT class="COREFERENCE" eid="e43">Manufacture</EVENT> <EVENT class="COREFERENCE" eid="e44">Commercialization</EVENT> or <EVENT class="COREFERENCE" eid="e45">use</EVENT> of the Antibody or Product or that claims or Covers Aimmune Know-How, or (ii) is an Aimmune Collaboration Patent. . "Aimmune Technology" means Aimmune Know-How and Aimmune Patents. . "Antibody" means Xencor's humanized antibody known as XmAb having the sequence listed in Schedule . . . "Anti-Corruption Laws" means the U.S. Foreign Corrupt Practices Act, as amended, the UK Bribery Act , as amended, as well as Applicable Law related to the <EVENT class="COREFERENCE" eid="e46">prevention</EVENT> of <EVENT class="COREFERENCE" eid="e47">fraud</EVENT> <EVENT class="COREFERENCE" eid="e48">racketeering</EVENT> <EVENT class="COREFERENCE" eid="e49">money</EVENT> laundering or <EVENT class="COREFERENCE" eid="e50">terrorism</EVENT> . "Applicable Law" means any applicable United States federal, state or local or foreign or multinational law, statute, standard, ordinance, code, rule, regulation, resolution or promulgation, or any <EVENT class="COREFERENCE" eid="e51">order</EVENT> <EVENT class="COREFERENCE" eid="e52">writ</EVENT> <EVENT class="COREFERENCE" eid="e53">judgment</EVENT> <EVENT class="COREFERENCE" eid="e54">injunction</EVENT> <EVENT class="COREFERENCE" eid="e55">decree</EVENT> <EVENT class="COREFERENCE" eid="e56">stipulation</EVENT> <EVENT class="COREFERENCE" eid="e57">ruling</EVENT> <EVENT class="COREFERENCE" eid="e58">determination</EVENT> or <EVENT class="COREFERENCE" eid="e59">award</EVENT> entered by or with any Governmental Authority, or any license, franchise, permit or similar right granted under any of the foregoing, or any similar provision having the force or effect of law. For the avoidance of doubt, any specific references to any Applicable Law or any portion thereof, shall be <EVENT class="COREFERENCE" eid="e60">deemed</EVENT> to <EVENT class="COREFERENCE" eid="e61">include</EVENT> all then- current amendments thereto or any replacement or successor law, statute, standard, ordinance, code, rule, regulation, resolution, <EVENT class="COREFERENCE" eid="e62">order</EVENT> <EVENT class="COREFERENCE" eid="e63">writ</EVENT> <EVENT class="COREFERENCE" eid="e64">judgment</EVENT> <EVENT class="COREFERENCE" eid="e65">injunction</EVENT> <EVENT class="COREFERENCE" eid="e66">decree</EVENT> <EVENT class="COREFERENCE" eid="e67">stipulation</EVENT> <EVENT class="COREFERENCE" eid="e68">ruling</EVENT> or <EVENT class="COREFERENCE" eid="e69">determination</EVENT> thereto. Source: AIMMUNE THERAPEUTICS, INC., -K, / / . "Baseline Quarter Net Sales" means, on a country-by-country and Product-by-Product basis, the average cumulative Net Sales of such Product in such country during the [***] Calendar Quarters that [***]precede the Calendar Quarter during which a Generic Product with respect to such Product is first commercially sold in such country. For example, if a Generic Product with respect to a <EVENT class="COREFERENCE" eid="e70">given</EVENT> Product is commercially <EVENT class="COREFERENCE" eid="e71">sold</EVENT> in the U.S. for the first time on [***], then the Baseline Quarter Net Sales with respect to such Product and U.S. are the cumulative Net Sales of such Product in the U.S. during the [***] Calendar Quarters of [***] <EVENT class="COREFERENCE" eid="e72">divided</EVENT> by [***]. . "Business Day" means a day other than a Saturday , Sunday , or bank or other public holiday in California. . "Calendar Quarter" means each three ( ) month period commencing January , April , July or October of any year ; provided, however, that (a) the first Calendar Quarter of the Term shall extend from the Effective Date to the end of the first full Calendar Quarter thereafter, and (b) the last Calendar Quarter of the Term shall <EVENT class="COREFERENCE" eid="e73">end</EVENT> upon the <EVENT class="COREFERENCE" eid="e74">expiration</EVENT> or <EVENT class="COREFERENCE" eid="e75">termination</EVENT> of this Agreement. . "Calendar Year" means the period beginning on the st of January and ending on the st of December of the same year ; provided, however, that (a) the first Calendar Year of the Term shall <EVENT class="COREFERENCE" eid="e76">commence</EVENT> on the Effective Date and <EVENT class="COREFERENCE" eid="e77">end</EVENT> on December of the same year and (b) the last Calendar Year of the Term shall commence on January of the Calendar Year in which this Agreement terminates or expires and end on the date of <EVENT class="COREFERENCE" eid="e78">termination</EVENT> or <EVENT class="COREFERENCE" eid="e79">expiration</EVENT> of this Agreement. . "Clinical <EVENT class="COREFERENCE" eid="e80">Trial</EVENT> means a clinical <EVENT class="COREFERENCE" eid="e81">trial</EVENT> including any a Phase I Clinical <EVENT class="COREFERENCE" eid="e82">Trial</EVENT> Phase II Clinical <EVENT class="COREFERENCE" eid="e83">Trial</EVENT> Phase III Clinical <EVENT class="COREFERENCE" eid="e84">Trial</EVENT> or Phase IV Clinical <EVENT class="COREFERENCE" eid="e85">Trial</EVENT> as the case may be, and as any such <EVENT class="COREFERENCE" eid="e86">trial</EVENT> is defined by an applicable Regulatory Authority. . " Co -pay <EVENT class="COREFERENCE" eid="e87">Program</EVENT> means a <EVENT class="COREFERENCE" eid="e88">program</EVENT> to support patient access to a Product whereby the Product manufacturer makes <EVENT class="COREFERENCE" eid="e89">payments</EVENT> to a Third Party equal to all or part of the difference between the price of Product prescribed to a patient and the amount such patient pays for such Product through such patient's insurance plan. . "Combination Product" means any Product containing an Active Ingredient that is not an Antibody. Such Combination Product shall be either (a) <EVENT class="COREFERENCE" eid="e90">priced</EVENT> and <EVENT class="COREFERENCE" eid="e91">sold</EVENT> in a single package <EVENT class="COREFERENCE" eid="e92">containing</EVENT> such multiple products or (b) <EVENT class="COREFERENCE" eid="e93">packaged</EVENT> separately but <EVENT class="COREFERENCE" eid="e94">sold</EVENT> together for a single price. . "Commercialize" means, with respect to the Product, to promote, market, distribute, sell (and offer for sale or contract to sell), import, export, or otherwise commercially exploit or provide product <EVENT class="COREFERENCE" eid="e95">support</EVENT> for the Product and to conduct <EVENT class="COREFERENCE" eid="e96">activities</EVENT> other than <EVENT class="COREFERENCE" eid="e97">Development</EVENT> or <EVENT class="COREFERENCE" eid="e98">Manufacturing</EVENT> in <EVENT class="COREFERENCE" eid="e99">preparation</EVENT> for conducting the foregoing <EVENT class="COREFERENCE" eid="e100">activities</EVENT> including <EVENT class="COREFERENCE" eid="e101">activities</EVENT> to produce commercialization support data and to secure and maintain market access and <EVENT class="COREFERENCE" eid="e102">reimbursement</EVENT> " <EVENT class="COREFERENCE" eid="e103">Commercializing</EVENT> " and "<EVENT class="COREFERENCE" eid="e104">Commercialization</EVENT> shall have correlative meanings. For the avoidance of doubt, Commercialization does not <EVENT class="COREFERENCE" eid="e105">include</EVENT> Development and Manufacturing. Source: AIMMUNE THERAPEUTICS, INC., -K, / / . "Commercially Reasonable <EVENT class="COREFERENCE" eid="e106">Efforts</EVENT> means, with respect to the <EVENT class="COREFERENCE" eid="e107">efforts</EVENT> to be expended by a Party with respect to any objective (e.g., Development <EVENT class="COREFERENCE" eid="e108">Activities</EVENT> and <EVENT class="COREFERENCE" eid="e109">Commercialization</EVENT> hereunder), the level of <EVENT class="COREFERENCE" eid="e110">efforts</EVENT> consistent with the <EVENT class="COREFERENCE" eid="e111">efforts</EVENT> and resources [***] of similar market potential, at a similar stage in <EVENT class="COREFERENCE" eid="e112">development</EVENT> or product lifecycle, taking into account the stage of <EVENT class="COREFERENCE" eid="e113">development</EVENT> or product lifecycle of other of [***] product candidates, safety and efficacy, product profile, cost of goods, the competitiveness of the marketplace, such company's patent position with respect to such product (including such company's ability to obtain or enforce, or have obtained or enforced, such patent rights), the Third Party patent landscape relevant to the product, the regulatory structure involved, the likelihood of regulatory <EVENT class="COREFERENCE" eid="e114">approval</EVENT> the likelihood and extent of anticipated or actual profitability of the applicable product, and other technical, legal, scientific and medical considerations. Without <EVENT class="COREFERENCE" eid="e115">limiting</EVENT> the foregoing, Commercially Reasonable <EVENT class="COREFERENCE" eid="e116">Efforts</EVENT> <EVENT class="COREFERENCE" eid="e117">requires</EVENT> , with respect to such obligations, that a Party: (i) promptly <EVENT class="COREFERENCE" eid="e118">assign</EVENT> responsibility for such obligation to specific employee(s) who are <EVENT class="COREFERENCE" eid="e119">held</EVENT> accountable for <EVENT class="COREFERENCE" eid="e120">progress</EVENT> and <EVENT class="COREFERENCE" eid="e121">monitor</EVENT> such <EVENT class="COREFERENCE" eid="e122">progress</EVENT> on an on- <EVENT class="COREFERENCE" eid="e123">going</EVENT> basis, (ii) set objectives for <EVENT class="COREFERENCE" eid="e124">carrying</EVENT> out such obligations, and (iii) <EVENT class="COREFERENCE" eid="e125">allocate</EVENT> resources <EVENT class="COREFERENCE" eid="e126">designed</EVENT> to <EVENT class="COREFERENCE" eid="e127">advance</EVENT> <EVENT class="COREFERENCE" eid="e128">progress</EVENT> with respect to such objectives. . "Control" or " Controlled by" means, with respect to any Know-How, Invention, Patent, technology, copyright, trademark or other intellectual property right, possession by a Party or its Affiliates (whether by ownership, license grant or other means) of the legal right to grant the right to access or use, or to grant a license or a sublicense to, such Know-How, Invention, Patent, technology, copyright, trademark or other intellectual property right as provided for herein without violating the proprietary rights of any Third Party or any terms of any agreement or other arrangement between such Party (or any of its Affiliates) and any Third Party. . "Cover" or " Covering " means, with respect to a particular subject matter at issue and a relevant Patent, that the <EVENT class="COREFERENCE" eid="e129">manufacture</EVENT> <EVENT class="COREFERENCE" eid="e130">use</EVENT> <EVENT class="COREFERENCE" eid="e131">sale</EVENT> <EVENT class="COREFERENCE" eid="e132">offer</EVENT> for <EVENT class="COREFERENCE" eid="e133">sale</EVENT> or <EVENT class="COREFERENCE" eid="e134">importation</EVENT> of such subject matter would, but for the existence of this Agreement, infringe one or more <EVENT class="COREFERENCE" eid="e135">claims</EVENT> in such Patents (or in the case of a Patent application, would infringe if such application were to issue). . "Designated Officer" means, with respect to Xencor, the Chief Executive Officer of Xencor (or its designee), and, with respect to Aimmune, the Chief Executive Officer of Aimmune (or its designee). . "Develop" means to research, develop, analyze, test and conduct preclinical <EVENT class="COREFERENCE" eid="e136">trials</EVENT> Clinical <EVENT class="COREFERENCE" eid="e137">Trials</EVENT> (including, for the avoidance of doubt, Phase IV Clinical <EVENT class="COREFERENCE" eid="e138">Trials</EVENT> and any preclinical/clinical/CMC commitments following Regulatory <EVENT class="COREFERENCE" eid="e139">Approval</EVENT> and all other regulatory <EVENT class="COREFERENCE" eid="e140">trials</EVENT> for the Product, as well as any and all <EVENT class="COREFERENCE" eid="e141">activities</EVENT> pertaining to manufacturing <EVENT class="COREFERENCE" eid="e142">development</EVENT> formulation <EVENT class="COREFERENCE" eid="e143">development</EVENT> medical <EVENT class="COREFERENCE" eid="e144">affairs</EVENT> and lifecycle <EVENT class="COREFERENCE" eid="e145">management</EVENT> including new <EVENT class="COREFERENCE" eid="e146">indications</EVENT> new <EVENT class="COREFERENCE" eid="e147">formulations</EVENT> and all other <EVENT class="COREFERENCE" eid="e148">activities</EVENT> including regulatory <EVENT class="COREFERENCE" eid="e149">activities</EVENT> related to securing and maintaining Regulatory <EVENT class="COREFERENCE" eid="e150">Approval</EVENT> for the Product, or otherwise characterizing or understanding the properties and <EVENT class="COREFERENCE" eid="e151">uses</EVENT> of the Antibody or the Product. " <EVENT class="COREFERENCE" eid="e152">Developing</EVENT> " and "<EVENT class="COREFERENCE" eid="e153">Development</EVENT> shall have correlative meanings. Source: AIMMUNE THERAPEUTICS, INC., -K, / / . "Development <EVENT class="COREFERENCE" eid="e154">Activities</EVENT> means those Development <EVENT class="COREFERENCE" eid="e155">activities</EVENT> undertaken by or on behalf of Aimmune with respect to the Product. . "Dollar" or "$" means the legal tender of the United States of America. . "E.U. Major Countries" means the United Kingdom, France, Germany, Italy, and Spain. . "FDA" means the United States Food and Drug Administration and any successor Regulatory Authority having substantially the same function. . "FD&C Act" means the U.S. Federal Food, Drug and Cosmetic Act, as amended, and the regulations promulgated thereunder. . "First Commercial <EVENT class="COREFERENCE" eid="e156">Sale</EVENT> means, with respect to a Product in any country, the first <EVENT class="COREFERENCE" eid="e157">shipment</EVENT> of such Product to a Third Party in such country for end <EVENT class="COREFERENCE" eid="e158">use</EVENT> or <EVENT class="COREFERENCE" eid="e159">consumption</EVENT> of such Product in such country after Regulatory <EVENT class="COREFERENCE" eid="e160">Approval</EVENT> of such Product in such country or, if earlier, the invoicing of a Third Party for such <EVENT class="COREFERENCE" eid="e161">shipment</EVENT> . "Force Majeure" means any circumstances whatsoever which are not within the reasonable control of the Party affected thereby, potentially including an <EVENT class="COREFERENCE" eid="e162">act</EVENT> of God, <EVENT class="COREFERENCE" eid="e163">war</EVENT> <EVENT class="COREFERENCE" eid="e164">act</EVENT> of terrorism, <EVENT class="COREFERENCE" eid="e165">insurrection</EVENT> <EVENT class="COREFERENCE" eid="e166">riot</EVENT> <EVENT class="COREFERENCE" eid="e167">strike</EVENT> or <EVENT class="COREFERENCE" eid="e168">labor</EVENT> dispute, <EVENT class="COREFERENCE" eid="e169">shortage</EVENT> of materials, <EVENT class="COREFERENCE" eid="e170">fire</EVENT> <EVENT class="COREFERENCE" eid="e171">explosion</EVENT> <EVENT class="COREFERENCE" eid="e172">flood</EVENT> <EVENT class="COREFERENCE" eid="e173">earthquake</EVENT> government <EVENT class="COREFERENCE" eid="e174">requisition</EVENT> or <EVENT class="COREFERENCE" eid="e175">allocation</EVENT> <EVENT class="COREFERENCE" eid="e176">breakdown</EVENT> of or <EVENT class="COREFERENCE" eid="e177">damage</EVENT> to plant, equipment or facilities, <EVENT class="COREFERENCE" eid="e178">interruption</EVENT> or <EVENT class="COREFERENCE" eid="e179">delay</EVENT> in <EVENT class="COREFERENCE" eid="e180">transportation</EVENT> fuel supplies or electrical power, <EVENT class="COREFERENCE" eid="e181">embargo</EVENT> <EVENT class="COREFERENCE" eid="e182">boycott</EVENT> <EVENT class="COREFERENCE" eid="e183">order</EVENT> or <EVENT class="COREFERENCE" eid="e184">act</EVENT> of civil or military authority. . "Generic Product" means, with respect to a Product and on a country-by-country basis, a product that (a) is marketed for <EVENT class="COREFERENCE" eid="e185">sale</EVENT> in such country [***], (b) contains or comprises an antibody with the [***], (c) is approved [***], and (d) such product, as and to the extent required, is approved through an abbreviated process based in reliance, at least in part, on the safety and efficacy data generated for the prior Regulatory <EVENT class="COREFERENCE" eid="e186">Approval</EVENT> of such Product by Aimmune or an Aimmune Agreement Entity in such country (similar, with respect to the United States, to an Abbreviated New Drug Applications under Section (j) of the FD&C Act ( USC (j))) or is approved as a "Biosimilar Biologic Product" under Title VII, Subtitle A Biologics Price Competition and Innovation Act of , Section U.S.C. , Section of the PHSA, or, outside the United States, in accordance with European Directive / /EC on the Community Code for medicinal products (Article ( ) and Section , Part II of Annex I) and European Regulation EEC/ / establishing the community procedures for the <EVENT class="COREFERENCE" eid="e187">authorization</EVENT> and <EVENT class="COREFERENCE" eid="e188">evaluation</EVENT> of medicinal products, each as amended, and together with all associated guidance, and any counterparts thereof or equivalent process inside or outside of the United States or EU to the foregoing.
</TEXT>
<MAKEINSTANCE aspect="NONE" eiid="ei15112" eventID="e0" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15113" eventID="e1" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15114" eventID="e2" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15115" eventID="e3" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15116" eventID="e4" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15117" eventID="e5" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15118" eventID="e6" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15119" eventID="e7" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15120" eventID="e8" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15121" eventID="e9" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15122" eventID="e10" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15123" eventID="e11" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15124" eventID="e12" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15125" eventID="e13" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15126" eventID="e14" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15127" eventID="e15" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15128" eventID="e16" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15129" eventID="e17" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15130" eventID="e18" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15131" eventID="e19" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15132" eventID="e20" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15133" eventID="e21" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15134" eventID="e22" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15135" eventID="e23" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15136" eventID="e24" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15137" eventID="e25" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15138" eventID="e26" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15139" eventID="e27" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15140" eventID="e28" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15141" eventID="e29" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15142" eventID="e30" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15143" eventID="e31" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15144" eventID="e32" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15145" eventID="e33" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15146" eventID="e34" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15147" eventID="e35" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15148" eventID="e36" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15149" eventID="e37" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15150" eventID="e38" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15151" eventID="e39" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15152" eventID="e40" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15153" eventID="e41" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15154" eventID="e42" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15155" eventID="e43" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15156" eventID="e44" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15157" eventID="e45" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15158" eventID="e46" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15159" eventID="e47" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15160" eventID="e48" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15161" eventID="e49" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15162" eventID="e50" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15163" eventID="e51" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15164" eventID="e52" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15165" eventID="e53" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15166" eventID="e54" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15167" eventID="e55" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15168" eventID="e56" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15169" eventID="e57" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15170" eventID="e58" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15171" eventID="e59" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15172" eventID="e60" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15173" eventID="e61" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15174" eventID="e62" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15175" eventID="e63" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15176" eventID="e64" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15177" eventID="e65" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15178" eventID="e66" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15179" eventID="e67" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15180" eventID="e68" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15181" eventID="e69" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15182" eventID="e70" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15183" eventID="e71" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15184" eventID="e72" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15185" eventID="e73" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15186" eventID="e74" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15187" eventID="e75" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15188" eventID="e76" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15189" eventID="e77" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15190" eventID="e78" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15191" eventID="e79" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15192" eventID="e80" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15193" eventID="e81" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15194" eventID="e82" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15195" eventID="e83" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15196" eventID="e84" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15197" eventID="e85" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15198" eventID="e86" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15199" eventID="e87" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15200" eventID="e88" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15201" eventID="e89" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15202" eventID="e90" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15203" eventID="e91" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15204" eventID="e92" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15205" eventID="e93" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15206" eventID="e94" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15207" eventID="e95" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15208" eventID="e96" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15209" eventID="e97" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15210" eventID="e98" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15211" eventID="e99" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15212" eventID="e100" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15213" eventID="e101" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15214" eventID="e102" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15215" eventID="e103" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15216" eventID="e104" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15217" eventID="e105" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15218" eventID="e106" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15219" eventID="e107" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15220" eventID="e108" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15221" eventID="e109" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15222" eventID="e110" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15223" eventID="e111" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15224" eventID="e112" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15225" eventID="e113" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15226" eventID="e114" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15227" eventID="e115" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15228" eventID="e116" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15229" eventID="e117" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15230" eventID="e118" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15231" eventID="e119" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15232" eventID="e120" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15233" eventID="e121" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15234" eventID="e122" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15235" eventID="e123" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15236" eventID="e124" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15237" eventID="e125" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15238" eventID="e126" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15239" eventID="e127" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15240" eventID="e128" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15241" eventID="e129" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15242" eventID="e130" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15243" eventID="e131" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15244" eventID="e132" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15245" eventID="e133" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15246" eventID="e134" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15247" eventID="e135" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15248" eventID="e136" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15249" eventID="e137" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15250" eventID="e138" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15251" eventID="e139" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15252" eventID="e140" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15253" eventID="e141" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15254" eventID="e142" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15255" eventID="e143" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15256" eventID="e144" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15257" eventID="e145" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15258" eventID="e146" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15259" eventID="e147" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15260" eventID="e148" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15261" eventID="e149" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15262" eventID="e150" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15263" eventID="e151" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15264" eventID="e152" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15265" eventID="e153" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15266" eventID="e154" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15267" eventID="e155" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15268" eventID="e156" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15269" eventID="e157" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15270" eventID="e158" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15271" eventID="e159" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15272" eventID="e160" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15273" eventID="e161" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15274" eventID="e162" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15275" eventID="e163" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15276" eventID="e164" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15277" eventID="e165" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15278" eventID="e166" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15279" eventID="e167" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15280" eventID="e168" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15281" eventID="e169" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15282" eventID="e170" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15283" eventID="e171" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15284" eventID="e172" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15285" eventID="e173" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15286" eventID="e174" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15287" eventID="e175" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15288" eventID="e176" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15289" eventID="e177" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15290" eventID="e178" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15291" eventID="e179" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15292" eventID="e180" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15293" eventID="e181" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15294" eventID="e182" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15295" eventID="e183" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15296" eventID="e184" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15297" eventID="e185" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15298" eventID="e186" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15299" eventID="e187" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei15300" eventID="e188" polarity="POS" pos="NOUN" tense="NONE" />
</TimeML>